Product Information

BRIVIACT 25 MG TABLET is a brand product labeled by UCB, Inc., priced at $24.0537 per EA under NDC 50474047009. Its NADAC has been published 374 times since Sep 18, 2019.

FDA first approved this application on May 12, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BRIVIACT 25 MG TABLET

brivaracetam
$24.0537per EA
DEA Schedule CV

Strength

25 mg/1

Manufacturer

UCB, Inc.

NDC

50474047009

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

BRIVARACETAM

Approval Type

New Drug (NDA)

FDA Application

NDA205836

FDA Approved

5/12/2016

TE Code

AB

On Market Since

5/12/2016

Pharmacological Classes

Epoxide Hydrolase Inhibitors

Price Statistics

The NADAC for BRIVIACT 25 MG TABLET has been published 374 times since Sep 18, 2019, and over the history we have for it it has risen 31.0%. The table below summarizes its recorded NADAC range and movement.

Current price$24.0537 per EA
All-time high$24.0782 (Jun 10, 2026)
All-time low$18.3614 (Sep 18, 2019)
52-week high$24.0782
52-week low$23.4456
Median price$21.9027
Average price$21.4229
Largest weekly change+6.9% (Jan 12, 2022)
Weeks tracked374
Tracking sinceSep 18, 2019

Price History

1W

0.0%

1M

-0.1%

3M

-0.0%

6M

-0.1%

1Y

+2.7%

3Y

+10.3%

5Y

+24.3%

All

+31.0%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BRIVIACT 25 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for BRIVIACT 25 MG TABLET, manufactured by UCB, Inc., is $24.0537 per EA (NDC 50474047009), effective Nov 11, 2026.

How has the price of BRIVIACT 25 MG TABLET changed over time?

Over the history we have for it, the NADAC for BRIVIACT 25 MG TABLET has risen 31.0%. It has been tracked across 374 weekly CMS publications since Sep 18, 2019.

What are the highest and lowest recorded NADAC prices for BRIVIACT 25 MG TABLET?

Since Sep 18, 2019, the NADAC for BRIVIACT 25 MG TABLET has ranged from a low of $18.3614 (Sep 18, 2019) to a high of $24.0782 (Jun 10, 2026), with a median of $21.9027 per EA.

Are there cheaper alternatives to BRIVIACT 25 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BRIVIACT 25 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures BRIVIACT 25 MG TABLET?

BRIVIACT 25 MG TABLET (NDC 50474047009) is labeled by UCB, Inc., and CMS classifies it as a brand product.